Nepal
DATOS

Our work in Nepal

Nepal - Strengthening laboratories for AMR and assessment of the  Mycobacterial Research Laboratory

Title: Fleming Fund inception phase

Code: D17-06

Date: January - May 2017

Location: Nepal & Myanmar

Client: Fleming Fund through Mott MacDonald

Type of services:

  • Providing input to proposal development for the Fleming Fund
  • Coordination of laboratory and surveillance strengthening activities under the Fleming Fund
  • Laboratory and surveillance system assessments for scoping missions for early investment countries of the Fleming Fund in Myanmar and Nepal

Report(s):

[5 Mar 2017] Linda Oskam is currently in Myanmar and Nepal on a scoping mission for the Fleming Fund to assess the antimicrobial resistance (AMR) situation and the surveillance capacity in these countries.


The Fleming Fund is an initiative of the UK Department of Health and aims to support around 30 countries worldwide to improve their AMR surveillance capacity up to the level that they can report to GLASS (Global Antimicrobial Resistance Surveillance System). One Health, sustainability, country ownership and alignment with policies and other initiatives are crucial to the program.


Mott MacDonald serves as the Fleming Fund Management Agent and Linda was hired to serve as a laboratory expert during the inception phase. Currently, Mott MacDonald teams are carrying out scoping missions to get a better understanding of the AMR surveillance situation in Myanmar, Nepal, Ghana and Uganda, to raise awareness among stakeholders, to test the approaches and tools that were developed so far and (ultimately) to get grant proposals from the countries involved.


In Myanmar we had a meeting with the Minister of Health and Sports, His Excellency Dr. Myint Htwe, who was very supportive. Source: //blog.datos-advice.nl/#post23


------


Title: Assessment of the Mycobacterial Research Laboratory

Code: D16-20

Date: December 2016

Location: Nepal

Client: The Leprosy Mission Nepal

Type of services:

Assessment of the Mycobacterial Research Laboratory with advice for future activities and improvements of current services.

Report(s):

[6 Dec 2016] From  5 to 7 December 2016 Linda Oskam was in Anandaban (Nepal, just south of Kathmandu) for the mid-term review of the research activities of Anandaban Hospital and the Mycobacterial Research Laboratory.


Anandaban Hospital provides specialized leprosy care for leprosy patients from all over Nepal with support from The Leprosy Mission Nepal and The Leprosy Mission International. Apart from diagnosis and treatment, care for complications, surgery and social rehabilitation, Anandaban Hospital also performs research into all aspects of leprosy. As leprosy is a neglected tropical disease that mostly hits the poorest people in developing countries, Anandaban Hospital and its Research Laboratory are one of the few remaining high level leprosy research centers in the world.


In 2007 and 2013, Linda Oskam was involved in the mid-term reviews of the research and laboratory activities. During the current review and assessment a team of 3 experts went over all the research activities and discussed current successes and challenges as well as opportunities for improvement and expansion. This will help Anandaban Hospital to continue its world class research activities that are crucial for our understanding of the biological, epidemiological and social context of leprosy and help to provide state of the art care for all leprosy patients worldwide. Source: //blog.datos-advice.nl/#post18


Want to know more? Check  our blog for  our latest activities or contact us!

Russian Federation
Caribbean Region
Sierra Leone
Switzerland
Denmark
Netherlands
France
Nigeria
Congo Brazzaville
Sudan
Rwanda
Zambia
Malawi
Ethiopia
Afghanistan
Uzbekistan
Tajikistan
Pakistan
Nepal
Kyrgyzstan
Mongolia
Laos PDR
Myanmar
Cambodia
Indonesia
Botswana
South Africa
Mozambique

CONTACT


Bargelaan 200

2333 CW Leiden

The Netherlands

T +31  (0)71 760 1657

contact(at)datos-advice.nl

DATOS is CRKBO registered